Christopher Louis Tsu started his career in IT development in 1986 at Apple Computer, where actively participated in the design of an international duplication system. In 1990, Tsu co-founded Britcomp Inc., which specialized in low-volume, high-value ASIC silicon hardware for government and military applications. He later co-founded Access Devices Digital Ltd., where he helped develop broadband internet over satellite systems and digital TV set-top boxes, contributing to the global shipment of millions of products. In 2006, Tsu founded LIT Inc., focusing on medical technology, specifically the development and patenting of dental biotech products. These products have been used to treat millions of patients worldwide. Alongside this venture, Tsu served as a strategic advisor to Falcon Technologies International LLC, involved in technology transfer and patent management. In June 2022, Christopher joined Venom Foundation, initially as the Chief Technical Executive. In this role, he led the technical development of the product, helping to complete the company’s entire ecosystem. Since June 2023 Tsu has been responsible for the company's general development in the role of CEO.